Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Carol A. Delaney"'
Publikováno v:
Journal of Adolescent & Adult Literacy. 65:419-429
Autor:
Lori Czop Assaf, Carol J. DeLaney
Publikováno v:
The Teacher Educator. 48:143-162
Building on Ball's (2009) model of generative change, we explored how two experienced literacy teachers, after completing a graduate-level multicultural literacy course, enacted the tenets of critical literacy. Ball defined teachers' generative think
Autor:
John A. Crolla, Regina Regan, Wayne Lam, Nicola Foulds, Colm Costigan, Carol A. Delaney, Sean Ennis, Amanda L. Collins, Sally Ann Lynch, James Iremonger, Bernt-Oves Hedberg, Göran Annerén, Freddie H. Sharkey, Caroline M Murray, David R. FitzPatrick, Ann-Charlotte Thuresson
Publikováno v:
Lynch, S A, Foulds, N, Thuresson, A-C, Collins, A L, Annerén, G, Hedberg, B-O, Delaney, C A, Iremonger, J, Murray, C M, Crolla, J A, Costigan, C, Lam, W, Fitzpatrick, D R, Regan, R, Ennis, S & Sharkey, F 2011, ' The 12q14 microdeletion syndrome : six new cases confirming the role of HMGA2 in growth ', European Journal of Human Genetics, vol. 19, no. 5, pp. 534-9 . https://doi.org/10.1038/ejhg.2010.215
We report six patients with array deletions encompassing 12q14. Out of a total of 2538 array investigations carried out on children with developmental delay and dysmorphism in three diagnostic testing centres, six positive cases yielded a frequency o
Publikováno v:
Middle School Journal. 39:38-43
Autor:
Pamela J. Dunston, Stephen Mogge, Rebecca Hunt, Victoria Gentry Ridgeway, Krishna Seunarinesingh, Kathy N. Headley, Nancy T. Walker, Sharon M. Pitcher, Lettie K. Albright, Sharon Peck, Carol J. DeLaney
Publikováno v:
Journal of Adolescent & Adult Literacy. 50:378-396
A team of researchers revised the Motivation to Read Profile for use with adolescents. Instruments to assess adolescents' in- and out-of-school reading motivations were administered. A survey adapted for adolescents was administered to 384 teens at e
Publikováno v:
Action in Teacher Education. 27:33-42
Ninety teachers working in award-winning middle schools responded to a survey that explored, quantitatively and qualitatively, how they (1) defined themselves as teachers of literacy, (2) viewed multiliteracies in adolescents' lives, and (3) valued t
Autor:
Howard Uderman, BN Swanson, Neville F. Ford, Irene Ferreira, Ole Vesterqvist, Wei‐chi Liao, Carol L. Delaney, Mohammed Jemal
Publikováno v:
British Journal of Clinical Pharmacology. 56:395-406
Aims To determine the pharmacokinetics, pharmacodynamics and tolerability of omapatrilat, a vasopeptidase inhibitor, in healthy subjects. Methods The effects of oral omapatrilat were evaluated in healthy men in two double-blind, placebo-controlled, d
Autor:
Carol L. Delaney, Kenneth C. Lasseter, Wei-Chi Liao, Vito M. Campese, Ramon Vargas, Carlos M. Ferrario, Clarence E. Grim, Michael C. Ruddy, William B. Smith, Ole Vesterqvist, Michael F. Habashy, Ronald D. Smith
Publikováno v:
Hypertension. 38:1342-1348
Omapatrilat, a vasopeptidase inhibitor, simultaneously inhibits neutral endopeptidase and ACE. The efficacy and hormonal profile of omapatrilat and lisinopril were compared in salt-sensitive hypertensive patients. On enrollment, antihypertensive medi
Autor:
Marc Klapholz, Georgia D. Kollia, Wei-Chi Liao, Carol L. Delaney, Ole Vesterqvist, John B. Kostis, Marvin Cohen, Mohammed Jemal, James A. Manning
Publikováno v:
The Journal of Clinical Pharmacology. 41:1280-1290
The purpose of this study was to determine the pharmacodynamics and pharmacokinetics of omapatrilat, administered orally (25 mg) or intravenously (10 mg) in 19 New York Heart Association class II and class III congestive heart failure (CHF) patients
Autor:
Wei‐chi Liao, Ole Vesterqvist, Irene Ferreira, James Manning, Howard Uderman, Carol L. Delaney
Publikováno v:
The Journal of Clinical Pharmacology. 41:1291-1300
Pharmacodynamic effects of combination therapy with omapatrilat and furosemide were evaluated. Two groups of 13 healthy subjects each received furosemide 20 mg daily for 15 days coadministered with either placebo on days 6 to 15 or omapatrilat 10 mg